- Home
- CLIR vs OTLK Comparison
CLIR vs OTLK Comparison
Compare CLIR & OTLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLIR | OTLK |
|---|---|---|
| Founded | 2008 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.3M | 29.2M |
| IPO Year | 2011 | 2016 |
Fundamental Metrics
Financial Performance| Metric | CLIR | OTLK |
|---|---|---|
| Price | $5.29 | $0.25 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $20.00 | $2.50 |
| AVG Volume (30 Days) | 82.8K | ★ 4.4M |
| Earning Date | 04-09-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 55.91 |
| EPS | N/A | ★ N/A |
| Revenue | $530,000.00 | ★ $8,146,123.00 |
| Revenue This Year | $89.55 | $1,430.98 |
| Revenue Next Year | $70.23 | $173.23 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.39 | $0.16 |
| 52 Week High | $7.56 | $3.39 |
Technical Indicators
Market Signals| Indicator | CLIR | OTLK |
|---|---|---|
| Relative Strength Index (RSI) | 61.89 | 38.87 |
| Support Level | $0.57 | $0.16 |
| Resistance Level | N/A | $0.46 |
| Average True Range (ATR) | 0.82 | 0.03 |
| MACD | 0.10 | 0.01 |
| Stochastic Oscillator | 44.21 | 39.33 |
Price Performance
Historical ComparisonAbout CLIR ClearSign Technologies Corporation (DE)
ClearSign Technologies Corp is engaged in designing and develop technologies for the purpose of decarbonization and improving key performance characteristics of industrial and commercial combustion systems, including emission and operational performance, energy efficiency and overall cost-effectiveness. Its ClearSign Core technology has been proved to be in full scale industrial test furnaces and boilers and first customer installations are currently operating in normal commercial applications The company offers products that include process burners, boiler burners, flares, and ClearSign Eye. The company operates in one segment: Combustion segment. The products of the company include: Process Burners, Midstream and Power, Flares, Boiler Burners, and Sensing Technology.
About OTLK Outlook Therapeutics Inc.
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA, which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.